Medicare Enrolled
Dr. Eric Lee, DO
Neurology · Silverdale, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lee
Dr. Eric Lee is a neurology specialist in Silverdale, WA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 21,804 Medicare services across 1,566 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lee received a total of $12,756 from 71 pharmaceutical and/or device companies across 614 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 2% volume in WA
$12,756 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,804
Medicare services
Top 2% in WA for neurology
1,566
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,283 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
13,600 | $5 | $18 |
| AbobotulinumtoxinA injection, 5 units An injection of abobotulinumtoxinA administered in a quantity of 5 units. |
6,300 | $6 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
746 | $88 | $366 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
391 | $117 | $477 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
169 | $47 | $182 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
133 | $135 | $516 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
73 | $83 | $327 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $64 | $260 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
64 | $115 | $448 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
50 | $43 | $162 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
48 | $75 | $287 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
47 | $113 | $509 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 29 | $59 | $228 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $70 | $322 |
| New patient office visit, complex (60-74 min) | 25 | $174 | $632 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
24 | $87 | $392 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
11 | $44 | $161 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,756
Total received (2018-2024)
Avg $1,822/year across 7 years
Top 13% in WA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
614
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,481 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$275 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,653
2023
$2,550
2022
$2,183
2021
$527
2020
$1,136
2019
$1,569
2018
$2,138
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$248
Lilly USA, LLC
$203
ABBVIE INC.
$193
Alexion Pharmaceuticals, Inc.
$179
EMD Serono, Inc.
$177
Eisai Inc.
$113
GENZYME CORPORATION
$112
ACADIA Pharmaceuticals Inc
$111
Lundbeck LLC
$110
ARGENX US, INC.
$92
Alnylam Pharmaceuticals Inc.
$86
Genentech USA, Inc.
$84
UCB, Inc.
$83
Neurocrine Biosciences, Inc.
$71
Biogen, Inc.
$66
Teva Pharmaceuticals USA, Inc.
$65
TG Therapeutics, Inc.
$61
Novartis Pharmaceuticals Corporation
$60
SK Life Science, Inc.
$60
JAZZ PHARMACEUTICALS INC.
$57
Otsuka America Pharmaceutical, Inc.
$56
Neurelis, Inc.
$54
Acorda Therapeutics, Inc
$50
Merz Pharmaceuticals, LLC
$46
Azurity Pharmaceuticals, Inc.
$42
Medtronic, Inc.
$30
Amneal Pharmaceuticals LLC
$29
LivaNova USA, Inc.
$29
Sumitomo Pharma America, Inc.
$24
Ipsen Biopharmaceuticals, Inc
$22
Amgen Inc.
$21
ITF Therapeutics LLC
$19
Top 3 companies account for 24.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,497
Abbott Laboratories
$621
Lilly USA, LLC
$593
Alexion Pharmaceuticals, Inc.
$550
GENZYME CORPORATION
$528
ABBVIE INC.
$484
EMD Serono, Inc.
$461
Amgen Inc.
$458
Lundbeck LLC
$417
Biogen, Inc.
$403
ACADIA Pharmaceuticals Inc
$371
PFIZER INC.
$349
UCB, Inc.
$336
Teva Pharmaceuticals USA, Inc.
$323
ARGENX US, INC.
$301
SK Life Science, Inc.
$300
IMPEL PHARMACEUTICALS INC.
$297
Genentech USA, Inc.
$270
Acorda Therapeutics, Inc
$269
Amneal Pharmaceuticals LLC
$252
Neurocrine Biosciences, Inc.
$220
Medtronic, Inc.
$210
Merz Pharmaceuticals, LLC
$205
Allergan Inc.
$169
Neurelis, Inc.
$148
Sumitomo Pharma America, Inc.
$139
Sunovion Pharmaceuticals Inc.
$133
CSL Behring
$130
Biohaven Pharmaceutical Holding Company Ltd.
$118
Eisai Inc.
$113
Grifols USA, LLC
$111
Alnylam Pharmaceuticals Inc.
$105
Janssen Pharmaceuticals, Inc
$95
UPSHER-SMITH LABORATORIES LLC
$95
Amylyx Pharmaceuticals, Inc.
$93
Impax Laboratories, Inc.
$93
Celgene Corporation
$91
Adamas Pharmaceuticals, Inc.
$79
Otsuka America Pharmaceutical, Inc.
$76
Medtronic USA, Inc.
$75
CATALYST PHARMACEUTICALS, INC.
$72
Upsher-Smith Laboratories LLC
$70
US WorldMeds, LLC
$68
Ipsen Biopharmaceuticals, Inc
$66
Azurity Pharmaceuticals, Inc.
$63
Kyowa Kirin, Inc.
$63
TG Therapeutics, Inc.
$61
Avanir Pharmaceuticals, Inc.
$57
JAZZ PHARMACEUTICALS INC.
$57
TG THERAPEUTICS, INC.
$54
Avion Pharmaceuticals
$53
Bausch Health US, LLC
$46
LivaNova USA, Inc.
$44
AbbVie Inc.
$44
GE HEALTHCARE
$40
Boston Scientific Corporation
$37
ASSERTIO THERAPEUTICS, Inc.
$32
Mitsubishi Tanabe Pharma America, Inc.
$25
Cala Health, Inc.
$23
Vertical Pharmaceuticals, LLC
$21
BANNER LIFE SCIENCES, LLC
$20
Horizon Therapeutics plc
$19
MDD US Operations, LLC
$19
Xeris Pharmaceuticals, Inc.
$19
ITF Therapeutics LLC
$19
Resmed Corp
$17
BOSTON SCIENTIFIC CORPORATION
$17
Supernus Pharmaceuticals, Inc.
$14
Allergan, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
Currax Pharmaceuticals LLC
$13
Top 3 companies account for 21.3% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · Aimovig · Astral · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CALA TRIO · COMIRNATY · CONTRAVE · Cambia · DIVIGEL · Dhivy · Dysport · EMGALITY · EPIDIOLEX · FIRDAPSE · GENERAL DBS · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuromodulation Dspsbls and Accs · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · Ponvory · Proclaim Family of SCS IPGs · Proclaim IPG · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · Soliris · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYVGART · VYVGART HYTRULO · Vimpat · WELLBUTRIN · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
254
Per 100K population
91.8
County median income
$98,546
Nearest hospital
HARRISON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lee is a mixed practice specialist, with above-average Medicare volume (top 2% in WA), with low-engagement industry engagement in the top 13% of WA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lee experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Lee performed 13,600 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $12,756 from 71 companies across 614 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other neurologists in Silverdale?
Dr. Lee's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Silverdale
Browse neurologists in Silverdale ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in WA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in WA
Which WA neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology